Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q3 2021 · 10-Q
Revenue$2.50B$2.50B+14.4% vs Q3 2020 Net Income$44.13M$44.13M−4.2% vs Q3 2020 EPS Diluted$0.58$0.58−23.7% vs Q3 2020 Gross Profit$328,839,000−4.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$61,430,000−47.8% Free Cash Flowderived$49,614,000−52.7% Margins · derivedGross margin13.1%−2.6 pt vs Q3 2020
Operating margin2.5%−0.9 pt vs Q3 2020
Net margin1.8%−0.3 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 3, 2021 · 34 d after period end